The DOI matches its Crossref record; 377 of the 377 references it cites were found in a registry or an index.
Antituberculosis drugs: Ten years of research
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–377 of 377
Mailaender, C., Reiling, N., Engelhardt, H., Bossmann, S. H., Ehlers, S., & Niederweis, M. (2004) · Microbiology · doi:10.1099/mic.0.26902-0 · Cited by 120
Frénois, F., Engohang‐Ndong, J., Locht, C., Baulard, A. R., & Villeret, V. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.09.020 · Cited by 120
Thiolactomycin, a new antibiotic. III. In vitro antibacterial activity.
NOTO, T., Miyakawa, S., OISHI, H., ENDO, H., & Okazaki, H. (1982) · The Journal of Antibiotics · doi:10.7164/antibiotics.35.401 · Cited by 120
Conformational Change of Elongation Factor Tu (EF-Tu) Induced by Antibiotic Binding
Vogeley, L., Palm, G. J., Mesters, J. R., & Hilgenfeld, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100017200 · Cited by 119
Sivaraman, S., Sullivan, T. J., Johnson, F., Novichenok, P., Cui, G., Simmerling, C. L., & Tonge, P. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030182i · Cited by 117
Molecular basis for triclosan activity involves a flipping loop in the active site
Qiu, X., Abdel‐Meguid, S. S., Janson, C. A., Court, R., Smyth, M. G., & Payne, D. J. (1999) · Protein Science · doi:10.1110/ps.8.11.2529 · Cited by 115
Discovery of Aminopyridine-Based Inhibitors of Bacterial Enoyl-ACP Reductase (FabI)
Miller, W. H., Seefeld, M. A., Newlander, K. A., Uzinskas, I. N., Burgess, W. J., Heerding, D. A., Yuan, C. C.-K., Head, M. S., Payne, D. J., Rittenhouse, S. F., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020050+ · Cited by 113
Lin, T., Melgar, M. M., Kurth, D. G., Swamidass, S. J., Purdon, J., Teresa, T., Gago, G., Baldi, P., Gramajo, H. C., & Tsai, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510580103 · Cited by 113
The effect of N,N′-dicyclohexylcarbodiimide on enzymes of bioenergetic relevance
Azzi, A., Casey, R. P., & Nałȩcz, M. J. (1984) · Biochimica et Biophysica Acta (BBA) - Reviews on Bioenergetics · doi:10.1016/0304-4173(84)90017-x · Cited by 112
2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ
White, E. L., Suling, W. J., Ross, L. J., Seitz, L. E., & Reynolds, R. C. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf075 · Cited by 111
Novel Inhibitors of Bacterial Cytokinesis Identified by a Cell-based Antibiotic Screening Assay
Stokes, N. R., Sievers, J., Barker, S., Bennett, J. M., Brown, D. R., Collins, I., Errington, V. M., Foulger, D., Hall, M. J., Halsey, R., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506741200 · Cited by 111
Expression of a Gene for a Porin-Like Protein of the OmpA Family fromMycobacterium tuberculosisH37Rv
Senaratne, R. H., Mobasheri, H., Papavinasasundaram, K. G., Jenner, P., Lea, E. J. A., & Draper, P. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.14.3541-3547.1998 · Cited by 110
Schiff base conjugates of p-aminosalicylic acid as antimycobacterial agents
Patole, J., Shingnapurkar, D., Padhyé, S., & Ratledge, C. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.12.035 · Cited by 108
Khoo, K., Douglas, E., Azadi, P., Inamine, J. M., Besra, G. S., Mikušová, K., Brennan, P. J., & Chatterjee, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28682 · Cited by 108
The Mechanism of Action of Inhibitors of Bacterial Two-component Signal Transduction Systems
Stephenson, K., Yamaguchi, Y., & Hoch, J. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006633200 · Cited by 107
Design, Synthesis, and SAR Studies of Mefloquine‐Based Ligands as Potential Antituberculosis Agents
Jayaprakash, S., Iso, Y., Wan, B., Franzblau, S. G., & Kozikowski, A. P. (2006) · ChemMedChem · doi:10.1002/cmdc.200600010 · Cited by 107
High-throughput screen for detecting antimycobacterial agents
Chung, G. A. C., Aktar, Z., Jackson, S., & Duncan, K. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.10.2235 · Cited by 107
Ronning, D. R., Vissa, V., Besra, G. S., Belisle, J. T., & Sacchettini, J. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400811200 · Cited by 105
Hurdle, J. G., O’Neill, A. J., Ingham, E., Fishwick, C. W. G., & Chopra, I. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4366-4376.2004 · Cited by 105
Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis
Rastogi, N., Goh, K. S., & David, H. L. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.5.759 · Cited by 104
Structure/Function Studies of Ser/Thr and Tyr Protein Phosphorylation in Mycobacterium tuberculosis
Greenstein, A. E., Grundner, C., Echols, N., Gay, L. M., Lombana, T. N., Miecskowski, C. A., Pullen, K. E., Sung, P.-Y., & Alber, T. (2005) · Microbial Physiology · doi:10.1159/000089645 · Cited by 104
Harrison, A. J., Yu, M., Gårdenborg, T., Middleditch, M., Ramsay, R. J., Baker, E. N., & Lott, J. S. (2006) · Journal of Bacteriology · doi:10.1128/jb.00338-06 · Cited by 104
Ring-substituted quinolines as potential anti-tuberculosis agents
Vangapandu, S., Jain, M., Jain, R., Kaur, S., & Pal Singh, P. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.03.045 · Cited by 103
Mahapatra, S., Scherman, H., Brennan, P. J., & Crick, D. C. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.7.2341-2347.2005 · Cited by 103
Essential Mechanisms in the Catalysis of Peptide Bond Formation on the Ribosome
Beringer, M., Bruell, C. M., Xiong, L., Pfister, P., Bieling, P., Katunin, V. I., Mankin, A. S., Böttger, E. C., & Rodnina, M. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507961200 · Cited by 103
Interspecies pharmacokinetics and in vitro metabolism of SQ109
Jia, L., Noker, P. E., Coward, L. C., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706650 · Cited by 102
Guardiola‐Diaz, H. M., Foster, L. A., Mushrush, D., & Vaz, A. D. N. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00571-8 · Cited by 100
Antimicrobial Evaluation of Nocathiacins, a Thiazole Peptide Class of Antibiotics
Pucci, M. J., Bronson, J. J., Barrett, J. F., DenBleyker, K. L., Discotto, L. F., Fung-Tomc, J. C., & Ueda, Y. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3697-3701.2004 · Cited by 100
THE CHANGING FACE OF TUBERCULOSIS
Huebner, R. E., & Castro, K. G. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.47 · Cited by 99
Nishida, I., Kawaguchi, A., & Yamada, M. (1986) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a135614 · Cited by 96
Slayden, R. A., Knudson, D. L., & Belisle, J. T. (2006) · Microbiology · doi:10.1099/mic.0.28762-0 · Cited by 96
Interaction of Pleuromutilin Derivatives with the Ribosomal Peptidyl Transferase Center
Long, K. S., Hansen, L. H., Jakobsen, L. A., & Vester, B. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1458-1462.2006 · Cited by 95
Synthesis and in vitro anti-mycobacterial activity of 5-substituted pyrimidine nucleosides
Johar, M., Manning, T., Kunimoto, D. Y., & Kumar, R. K. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.07.046 · Cited by 94
A New Class of Antituberculosis Agents
Jones, P. B., Parrish, N. M., Houston, T. A., Stapon, A., Bansal, N. P., Dick, J. D., & Townsend, C. A. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000149l · Cited by 92
Müller, D., Krick, A., Kehraus, S., Mehner, C., Hart, M. C., Küpper, F. C., Saxena, K., Prinz, H., Schwalbe, H., Janning, P., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060327w · Cited by 92
Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles
Kazimierczuk, Z., Andrzejewska, M., Kaustová, J., & Klimešová, V. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.10.004 · Cited by 92
Yanagisawa, T., Lee, J. T., Wu, H. C., & Kawakami, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51082-1 · Cited by 91
Structure-based drug design meets the ribosome
Franceschi, F. J., & Duffy, E. M. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.026 · Cited by 91
Paramasivan, C. N., Sulochana, S., Kubendiran, G., Venkatesan, P., & Mitchison, D. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.627-631.2005 · Cited by 91
Dalhoff, A., Janjić, N., & ECHOLS, R. M. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.003 · Cited by 91
Synthesis and Evaluation of Nitrofuranylamides as Novel Antituberculosis Agents
Tangallapally, R. P., Yendapally, R., Lee, R. E., Hevener, K. E., Jones, V., Lenaerts, A. J. M., McNeil, M., Wang, Y., Franzblau, S. G., & Lee, R. E. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049972y · Cited by 90
McFadden, J. M., Medghalchi, S. M., Thupari, J. N., Pinn, M. L., Vadlamudi, A., Miller, K. I., Kuhajda, F. P., & Townsend, C. A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049389h · Cited by 89
Bactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG
Murugasu-Oei, B. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.6.917 · Cited by 87
Datta, M., Radhamani, M. P., Selvaraj, R., et al. (1993) · Tubercle and Lung Disease · doi:10.1016/0962-8479(93)90008-l · Cited by 87
Azole antifungals as novel chemotherapeutic agents against murine tuberculosis
Ahmad, Z., Sharma, S., & Khuller, G. K. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00350.x · Cited by 86
Upton, A. M., Mushtaq, A., Victor, T. C., Sampson, S. L., Sandy, J., Smith, D., van Helden, P. D., & Sim, E. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02648.x · Cited by 86
Species-specific antibiotic-ribosome interactions: implications for drug development
Wilson, D. N., Harms, J., Nierhaus, K. H., Schlünzen, F., & Fucini, P. (2005) · Biological Chemistry · doi:10.1515/bc.2005.141 · Cited by 85
Koga, T., Fukuoka, T., Doi, N., Harasaki, T., Inoue, H., Hotoda, H., Kakuta, M., Muramatsu, Y., Yamamura, N., Hoshi, M., et al. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh417 · Cited by 85
Viveiros, M., David, S., & Amaral, L. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00199-0 · Cited by 83
Yang, Y., Severin, A. I., Chopra, R., Krishnamurthy, G., Singh, G., Hu, W. K., Keeney, D. R., Svenson, K., Petersen, P. J., Labthavikul, P., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.556-564.2006 · Cited by 83
A Serine/Threonine Protein Kinase fromMycobacterium tuberculosis
Peirs, P., Wit, L. D., Braibant, M., Huygen, K., & Content, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00604.x · Cited by 82
Rickman, L., Saldanha, J. W., Hunt, D. M., Hoar, D. N., Colston, M. J., Millar, J. B. A., & Buxton, R. S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.082 · Cited by 82
Mefloquine Is Active In Vitro and In Vivo againstMycobacterium aviumComplex
Bermudez, L. E., Kolonoski, P., Wu, M., Aralar, P., Inderlied, C. B., & Young, L. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1870 · Cited by 82
Kim, P., Zhang, Y., Shenoy, G. G., Nguyen, Q.-A., Boshoff, H. I., Manjunatha, U. H., Goodwin, M. B., Lonsdale, J., Price, A. C., Miller, D. J., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050825p · Cited by 81
Anaerobic incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis
Wade, M. M., & Zhang, Y. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45639-0 · Cited by 80
The biosynthesis of mycolic acids by Mycobacteria: current and alternative hypotheses
Asselineau, C., Asselineau, J., Lanéelle, G., & Lanéelle, M. (2002) · Progress in Lipid Research · doi:10.1016/s0163-7827(02)00008-5 · Cited by 79
Proteins unique to intraphagosomally grown Mycobacterium tuberculosis
Mattow, J., Siejak, F., Hagens, K., Becher, D., Albrecht, D., Krah, A., Schmidt, F., Jungblut, P. R., Kaufmann, S. H. E., & Schaible, U. E. (2006) · PROTEOMICS · doi:10.1002/pmic.200500547 · Cited by 78
Banfi, E., Scialino, G., Zampieri, D., Mamolo, M. G., Vio, L., Ferrone, M. L., Fermeglia, M., Paneni, M. S., & Pricl, S. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl182 · Cited by 78
3D-QSAR study of ring-substituted quinoline class of anti-tuberculosis agents
Nayyar, A., Malde, A. K., Jain, R., & Coutinho, E. C. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.09.018 · Cited by 77
Läppchen, T., Hartog, A. F., Pinas, V. A., Koomen, G., & den Blaauwen, T. (2005) · Biochemistry · doi:10.1021/bi047297o · Cited by 77
Qian, L., & de Montellano, P. R. O. (2006) · Chemical Research in Toxicology · doi:10.1021/tx050328b · Cited by 77
Beyer, D., Kroll, H., Endermann, R., Schiffer, G., Siegel, S., Bauser, M., Pohlmann, J., Brands, M., Ziegelbauer, K. B., Haebich, D., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.525-532.2004 · Cited by 76
Berg, S., Starbuck, J., Torrelles, J. B., Vissa, V., Crick, D. C., Chatterjee, D., & Brennan, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411418200 · Cited by 76
New Drugs for Tuberculosis: Current Status and Future Prospects
O'Brien, R. J., & Spigelman, M. (2005) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2005.02.013 · Cited by 75
Ashtekar, D. R., Costa-Periera, R., Shrinivasan, T., Iyyer, R., Vishvanathan, N., & RITTEL, W. (1991) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(91)90002-w · Cited by 74
Synthesis of glycosylated β-amino acids as new class of antitubercular agents
Tripathi, R. P., Tripathi, R. P., Tiwari, V. K., Bala, L., Sinha, S. K., Srivastava, A., Srivastava, A. K., & Srivastava, B. S. (2002) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(02)01398-3 · Cited by 74
Francisco, G. D., Li, Z., Albright, J. D., Eudy, N. H., Katz, A. H., Petersen, P. J., Labthavikul, P., Singh, G., Yang, Y., Rasmussen, B. A., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.082 · Cited by 74
Hlasta, D. J., Demers, J. P., Foleno, B. D., Fraga‐Spano, S. A., Guan, J., Hilliard, J. J., Macielag, M. J., Ohemeng, K. A., Sheppard, C. M., Sui, Z., et al. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00326-6 · Cited by 73
Use of IMiD3, a Thalidomide Analog, as an Adjunct to Therapy for Experimental Tuberculous Meningitis
Tsenova, L., Mangaliso, B., Muller, G. W., Chen, Y., Freedman, V. H., Stirling, D., & Kaplan, G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1887-1895.2002 · Cited by 72
Kremer, L., de Chastellier, C., Dobson, G., Gibson, K. J. C., Bifani, P. J., Balor, S., Gorvel, J., Locht, C., Minnikin, D. E., & Besra, G. S. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04717.x · Cited by 71
Identification and Characterization of Inhibitors of Bacterial Enoyl-Acyl Carrier Protein Reductase
Ling, L. L., Xian, J., Ali, S. M. A., Bolin, G., Fan, J., Mills, D. M., Arvanites, A. C., Orgueira, H. A., Ashwell, M. A., Carmel, G., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1541-1547.2004 · Cited by 71
Hunt, E. (2000) · Drugs of the Future · doi:10.1358/dof.2000.025.11.858699 · Cited by 71
Antimycobacterial activity of 5-arylidene derivatives of hydantoin
Kieć‐Kononowicz, K., & Szymańska, E. (2002) · Il Farmaco · doi:10.1016/s0014-827x(02)01292-2 · Cited by 70
Pathak, A. K., Pathak, V., Seitz, L. E., Maddry, J. A., Gurcha, S. S., Besra, G. S., Suling, W. J., & Reynolds, R. C. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00179-1 · Cited by 67
Mycobacterium tuberculosis gene expression profiling within the context of protein networks
Rachman, H., Strong, M., Schaible, U. E., Schuchhardt, J., Hagens, K., Mollenkopf, H., Eisenberg, D. S., & Kaufmann, S. H. E. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.09.011 · Cited by 67
Antitubercular Isoniazid and Drug Resistance of Mycobacterium tuberculosis — A Review
Scior, T., Morales, I. M., Garcés‐Eisele, S. J., Domeyer, D. M., & Laufer, S. (2002) · Archiv der Pharmazie · doi:10.1002/ardp.200290005 · Cited by 66
Antimicrobial Dihydrofolate Reductase Inhibitors - Achievements and Future Options: Review
Then, R. L. (2004) · Journal of Chemotherapy · doi:10.1179/joc.2004.16.1.3 · Cited by 66
Ducasse-Cabanot, S., Cohen‐Gonsaud, M., Marrakchi, H., Nguyen, M., Zerbib, D., Bernadou, J., Daffé, M., Labesse, G., & Quémard, A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.242-249.2004 · Cited by 66
Mycobacterium smegmatis d -Alanine Racemase Mutants Are Not Dependent on d -Alanine for Growth
Chacón, O., Feng, Z., Harris, N., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.47-54.2002 · Cited by 66
Anti-staphylococcal activity and mode of action of clofazimine
Oliva, B. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh114 · Cited by 65
Rose, J. D., Maddry, J. A., Comber, R. N., et al. (2002) · Carbohydrate Research · doi:10.1016/s0008-6215(01)00288-9 · Cited by 64
Ahmad, Z., Sharma, S., Khuller, G. K., Singh, P., Faujdar, J., & Katoch, V. M. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.07.028 · Cited by 64
Srivastava, S. K. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki1006 · Cited by 64
Substituted 4-methylquinolines as a new class of anti-tuberculosis agents
Jain, R., Vaitilingam, B., Nayyar, A., & Palde, P. B. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00074-x · Cited by 62
Levy, C., Baldock, C., Wallace, A. J., Sedelnikova, S. E., Viner, R. C., Clough, J. M., Stuitje, A. R., Slabas, A. R., Rice, D. W., & Rafferty, J. B. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4643 · Cited by 62
Foloppe, N., Chen, I., Davis, B. J., Hold, A., Morley, D., & Howes, R. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.12.023 · Cited by 62
In Vitro Activities of Cloxyquin (5-Chloroquinolin-8-ol) against Mycobacterium tuberculosis
Hongmanee, P., Rukseree, K., Buabut, B., Somsri, B., & Palittapongarnpim, P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01310-06 · Cited by 62
Seefeld, M. A., Miller, W. H., Newlander, K. A., Burgess, W. J., Payne, D. J., Rittenhouse, S. F., Moore, T. D., DeWolf, W. E., Keller, P. M., Qiu, X., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00405-x · Cited by 61
Synthesis and SAR of novel oxazolidinones: Discovery of ranbezolid
Das, B., Rudra, S., Yadav, A., Ray, A., Rao, A. V. S. R., Srinivas, A., Soni, A., Saini, S., Shukla, S., Pandya, M., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.06.063 · Cited by 61
Douglas, J. D., Senior, S. J., Morehouse, C. B., Phetsukiri, B., Campbell, I. B., Besra, G. S., & Minnikin, D. E. (2002) · Microbiology · doi:10.1099/00221287-148-10-3101 · Cited by 60
Identification and Validation of Novel Drug Targets in Tuberculosis
Duncan, K. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383223 · Cited by 60
Pretorius, G. S., van Helden, P. D., Sirgel, F. A., Eisenach, K. D., & Victor, T. C. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.10.2276 · Cited by 60
Gay, L. M., Ng, H. L., & Alber, T. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.05.015 · Cited by 60
Design and synthesis of indolo[2,3-a]quinolizin-7-one inhibitors of the ZipA–FtsZ interaction
Jennings, L. D., Foreman, K. W., Rush, T. S., Tsao, D. H. H., Mosyak, L., Li, Y., Sukhdeo, M. N., Ding, W., Dushin, E. G., Kenny, C. H., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.01.028 · Cited by 60
Santo, R. D., Costi, R., Artico, M., et al. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00526-5 · Cited by 59
Jarvis, B., & Lamb, H. M. (1998) · Drugs · doi:10.2165/00003495-199856040-00008 · Cited by 59
Centrone, C. A., & Lowary, T. L. (2002) · The Journal of Organic Chemistry · doi:10.1021/jo026247r · Cited by 58
Pleuromutilins. Part 1 The identification of novel mutilin 14-carbamates
Brooks, G., Burgess, W., Colthurst, D., Hinks, J. D., Hunt, E., Pearson, M. J., Shea, B., Takle, A. K., Wilson, J. M., & Woodnutt, G. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00338-2 · Cited by 58
Hotoda, H., Furukawa, M., Daigo, M., Murayama, K., Kaneko, M., Muramatsu, Y., Ishii, M. M., Miyakoshi, S., Takatsu, T., Inukai, M., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00596-1 · Cited by 58
Iron enhances the antituberculous activity of pyrazinamide
Somoskövi, Á. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh042 · Cited by 58
Jennings, L. D., Foreman, K. W., Rush, T. S., Tsao, D. H. H., Mosyak, L., Kincaid, S. L., Sukhdeo, M. N., Sutherland, A. G., Ding, W., Kenny, C. H., et al. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.07.031 · Cited by 57
Clinical Evaluation of Isoniazid
Middlebrook, G., & DRESSLER, S. H. (1954) · American Review of Tuberculosis · doi:10.1164/art.1954.70.6.1102 · Cited by 57
Pasqualoto, K. F. M., Ferreira, E. I., Santos‐Filho, O. A., & Hopfinger, A. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049913k · Cited by 56
Isoniazid Resistance and the Future of Drug-Resistant Tuberculosis
Cohen, T., Becerra, M. C., & Murray, M. B. (2004) · Microbial Drug Resistance · doi:10.1089/mdr.2004.10.280 · Cited by 56
Benzofuro[3,2-f][1]benzopyrans: A new class of antitubercular agents
Prado, S., Ledeit, H., Michel, S., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.03.033 · Cited by 56
Peptide Deformylase Inhibitors as Potent Antimycobacterial Agents
Teo, J. W. P., Thayalan, P., Beer, D., Yap, A., Nanjundappa, M., Ngew, X., Duraiswamy, J., Liung, S., Dartois, V. A., Schreiber, M., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00555-06 · Cited by 56
Dual Inhibition of Mycobacterial Fatty Acid Biosynthesis and Degradation by 2-Alkynoic Acids
Morbidoni, H. R., Vilchèze, C., Kremer, L., Bittman, R., Sacchettini, J. C., & Jacobs, W. R. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.01.005 · Cited by 55
Mizyed, S., Oddone, A., Byczynski, B., Hughes, D. W., & Berti, P. J. (2005) · Biochemistry · doi:10.1021/bi047704w · Cited by 55
Hanoulle, X., Wieruszeski, J., Rousselot‐Pailley, P., Landrieu, I., Locht, C., Lippens, G. M., & Baulard, A. R. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl332 · Cited by 55
Structure-based design of carboxybiphenylindole inhibitors of the ZipA–FtsZ interaction
Sutherland, A. G., Alvarez, J., Ding, W., Foreman, K. W., Kenny, C. H., Labthavikul, P., Mosyak, L., Petersen, P. J., Rush, T. S., Ruzin, A. V., et al. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b312016c · Cited by 54
Structure-Guided Discovery of Novel Aminoglycoside Mimetics as Antibacterial Translation Inhibitors
Zhou, Y., Gregor, V. E., Sun, Z., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.4942-4949.2005 · Cited by 54
Senior, S. J., Illarionov, P. A., Gurcha, S. S., Campbell, I. B., Schaeffer, M. L., Minnikin, D. E., & Besra, G. S. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.08.015 · Cited by 54
Rai, D., Johar, M., Manning, T., Agrawal, B., Kunimoto, D. Y., & Kumar, R. K. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058167w · Cited by 53
Rastogi, N., Goh, K. S., & Labrousse, V. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2843 · Cited by 53
New Benzylidenethiazolidinediones as Antibacterial Agents
Heerding, D. A., Christmann, L. T., Clark, T. J., Holmes, D. J., Rittenhouse, S. F., Takata, D. T., & Venslavsky, J. W. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.07.010 · Cited by 53
Antimycobacterial activity of cerulenin and its effects on lipid biosynthesis
Parrish, N. M. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.2.219 · Cited by 51
Martín-Galiano, A. J., Gorgojo, B., Kunin, C. M., & de la Campa, A. G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1680-1687.2002 · Cited by 51
Ōmura, S., IWAI, Y., Nakagawa, A., et al. (1983) · The Journal of Antibiotics · doi:10.7164/antibiotics.36.109 · Cited by 51
Synthesis and aminoacyl-tRNA synthetase inhibitory activity of aspartyl adenylate analogs
Bernier, S., Akochy, P., Lapointe, J., & Chênevert, R. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.09.055 · Cited by 50
Parrish, N. M., Houston, T. A., Jones, P. B., Townsend, C. A., & Dick, J. D. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1143-1150.2001 · Cited by 50
Novel, Selective Δ6 or Δ5 Fatty Acid Desaturase Inhibitors as Antiinflammatory Agents in Mice
Obukowicz, M. G., Welsch, D. J., Salsgiver, W. J., Martin-Berger, C. L., Chinn, K. S., Duffin, K. L., Raz, A., & Needleman, P. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37776-6 · Cited by 50
Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity
Kamal, Ä., Reddy, K. S., Ahmed, S. K., et al. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.08.063 · Cited by 49
Mutational Analysis of a Role for Salicylic Acid in Iron Metabolism of Mycobacterium smegmatis
Adilakshmi, T., Ayling, P. D., & Ratledge, C. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.2.264-271.2000 · Cited by 49
Monga, V., Nayyar, A., Vaitilingam, B., Palde, P. B., Jhamb, S. S., Kaur, S., Singh, P. P., & Jain, R. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.09.017 · Cited by 49
Mechanisms of persistence of mycobacteria
Britton, W. J., ROCHE, P. W., & Winter, N. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90005-1 · Cited by 48
Gaurrand, S., Desjardins, S., Meyer, C., et al. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2006.00410.x · Cited by 48
Nannini, E. C., Keating, M. J., Binstock, P., Samonis, G., & Kontoyiannis, D. P. (2002) · Journal of Infection · doi:10.1053/jinf.2002.0970 · Cited by 48
Jia, L., Coward, L. C., Gorman, G. S., Noker, P. E., & Tomaszewski, J. E. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087817 · Cited by 48
Manetti, F., Magnani, M., Castagnolo, D., Passalacqua, L., Botta, M., Corelli, F., Saddi, M., Deidda, D., & Logu, A. D. (2006) · ChemMedChem · doi:10.1002/cmdc.200600026 · Cited by 47
Gobec, S., Plantan, I., Mravljak, J., Švajger, U., Wilson, R. A., Besra, G. S., Soares, S. L., Appelberg, R., & Kikelj, D. (2006) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.08.007 · Cited by 47
David, S. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.3.391 · Cited by 46
Hanoulle, X., Wieruszeski, J., Rousselot‐Pailley, P., Landrieu, I., Baulard, A. R., & Lippens, G. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.197 · Cited by 43
Senior, S. J., Illarionov, P. A., Gurcha, S. S., Campbell, I. B., Schaeffer, M. L., Minnikin, D. E., & Besra, G. S. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.10.061 · Cited by 43
Kamal, Ä., Shaik, A. A., Sinha, R., Yadav, J. S., & Arora, S. K. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.01.084 · Cited by 42
Vaitilingam, B., Nayyar, A., Palde, P. B., Monga, V., Jain, R., Kaur, S., & Singh, P. P. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.05.018 · Cited by 41
Li, Z., Francisco, G. D., Hu, W. K., Labthavikul, P., Petersen, P. J., Severin, A. I., Singh, G., Yang, Y., Rasmussen, B. A., Lin, Y., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00471-2 · Cited by 40
Dutta, N. K., Dastidar, S. G., Kumar, A. R., Mazumdar, K., Ray, R., & Chakrabarty, A. N. (2004) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822004000300009 · Cited by 40
Structural basis for topoisomerase VI inhibition by the anti-Hsp90 drug radicicol
Corbett, K. D., & Berger, J. M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl567 · Cited by 39
Synthesis of galactopyranosyl amino alcohols as a new class of antitubercular and antifungal agents
Tewari, N., Tiwari, V. K., Tripathi, R. P., Chaturvedi, V., Srivastava, A., Srivastava, A. K., Shukla, P. K., Chaturvedi, A. K., Gaikwad, A. N., Sinha, S. K., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.11.020 · Cited by 39
Polymerization of Mycobacterial Arabinogalactan and Ligation to Peptidoglycan
Yagi, T., Mahapatra, S., Mikušová, K., Crick, D. C., & Brennan, P. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302216200 · Cited by 37
Ito, H., Ura, A., Oyamada, Y., Tanitame, A., Yoshida, H., Yamada, S., Wachi, M., & Yamagishi, J. (2006) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2006.tb03851.x · Cited by 36
Matsuura, K., Yoshioka, S., Tosha, T., Hori, H., Ishimori, K., Kitagawa, T., Morishima, I., Kagawa, N., & Waterman, M. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m413042200 · Cited by 35
Danelishvili, L., Wu, M., Young, L. S., & Bermudez, L. E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3707-3714.2005 · Cited by 34
Gallant, P., Finn, J., Keith, D. D., et al. (2000) · Emerging Therapeutic Targets · doi:10.1517/14728222.4.1.1 · Cited by 34
Frénois, F., Baulard, A. R., & Villeret, V. (2005) · Tuberculosis · doi:10.1016/j.tube.2005.07.005 · Cited by 34
Broussy, S., Bernardes‐Génisson, V., Quémard, A., Meunier, B., & Bernadou, J. (2005) · The Journal of Organic Chemistry · doi:10.1021/jo051901z · Cited by 33
Convenient Divergent Synthesis of a Library of Trehalosamine Analogues
Hui, Y., & Chang, C. T. (2002) · Organic Letters · doi:10.1021/ol026095m · Cited by 33
The effect of p-aminosalicyclic acid on iron transport and assimilation in mycobacteria
Brown, K. A., & Ratledge, C. (1975) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(75)90349-9 · Cited by 33
Synthesis and antimycobacterial activities of glycosylated amino alcohols and amines
Katiyar, D., Tiwari, V. K., Tewari, N., Verma, S. S., Sinha, S. K., Gaikwad, A. N., Srivastava, A. K., Chaturvedi, V., Srivastava, R., Srivastava, B. S., et al. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.12.002 · Cited by 33
Structure-based design of agents targeting the bacterial ribosome
Bower, J. F., Drysdale, M., Hebdon, R. J., Jordan, A. M., Lentzen, G., Matassova, N., Murchie, A. I. H., Powles, J., & Roughley, S. D. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00495-5 · Cited by 32
Fluoroquinolones as Chemotherapeutics Against Mycobacterial Infections
Jacobs, M. R. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383296 · Cited by 31
Antimycobacterial activity of 2-methyl-adenosine
Barrow, E. W., Westbrook, L., Bansal, N., Suling, W. J., Maddry, J. A., Wb, P., & Barrow, W. W. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg444 · Cited by 31
Gubler, M., Appoldt, Y., & Keck, W. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.3.906-910.1996 · Cited by 28
New α-methylene-γ-butyrolactones with antimycobacterial properties
Hughes, M. A., McFadden, J. M., & Townsend, C. A. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.119 · Cited by 28
Broussy, S., Coppel, Y., Nguyen, M., Bernadou, J., & Meunier, B. (2003) · Chemistry - A European Journal · doi:10.1002/chem.200204637 · Cited by 27
Mycobacterium tuberculosis: a model system for structural genomics
Smith, C. V., & Sacchettini, J. C. (2003) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2003.10.004 · Cited by 27
2‐Methoxylated fatty acids in marine sponges: Defense mechanism against mycobacteria?
Carballeira, N. M., Cruz, H., Kwong, C. D., Wan, B., & Franzblau, S. G. (2004) · Lipids · doi:10.1007/s11745-004-1281-8 · Cited by 26
Dwivedi, N., Tewari, N., Tiwari, V. K., Chaturvedi, V., Manju, Y. K., Srivastava, A., Giakwad, A., Sinha, S. K., & Tripathi, R. P. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.07.007 · Cited by 25
Recent advances towards identification of new drug targets for Mycobacterium tuberculosis
Sharma, K., Chopra, P., & Singh, Y. P. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.2.79 · Cited by 24
Kim, S. E., Kim, S. Y., Kim, S., Kang, T., & Lee, J. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.035 · Cited by 23
Bosco, M., Bisseret, P., Constant, P., & Eustache, J. (2006) · Tetrahedron Letters · doi:10.1016/j.tetlet.2006.10.151 · Cited by 22
Hearn, M. J., & Cynamon, M. H. (2003) · Drug design and discovery · doi:10.1080/10559610390450705 · Cited by 22
Poreddy, A. R., Schall, O. F., Marshall, G. R., Ratledge, C., & Słomczyńska, U. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00473-6 · Cited by 21
Isolation and structure of antibiotic U-68,204, a new thiolactone.
Dolak, L. A., Castle, T. M., TRUESDELL, S. E., et al. (1986) · The Journal of Antibiotics · doi:10.7164/antibiotics.39.26 · Cited by 21
Antimycobacterial activity of synthetic pamamycins
Lefèvre, P., Peirs, P., Braibant, M., Fauville‐Dufaux, M., Vanhoof, R., Huygen, K., Wang, X.-M., Pogell, B. M., Wang, Y., Fischer, P., et al. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh402 · Cited by 20
Effect of a diazaborine derivative (Sa 84.474) on the virulence of Escherichia coli
Lam, C., Turnowsky, F., Högenauer, G., & Schütze, E. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/20.1.37 · Cited by 20
Wheeler, P. R., Besra, G. S., Minnikin, D. E., et al. (1993) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.1993.tb01429.x · Cited by 19
Selective inhibition of divergent seryl‐tRNA synthetases by serine analogues
Ahel, D., Slade, D., Močibob, M., Söll, D. G., & Weygand-Đurašević, I. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.06.073 · Cited by 18
Dong, X., Bhamidi, S., Scherman, M., Xin, Y., & McNeil, M. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.4.2601-2605.2006 · Cited by 18
Broussy, S., Bernardes‐Génisson, V., Gornitzka, H., Bernadou, J., & Meunier, B. (2005) · Organic & Biomolecular Chemistry · doi:10.1039/b415439h · Cited by 16
Isolation and structure of citroethiolactone, a novel metabolite of Penicillium citreo-viride B.
Shizuri, Y., Niwa, M., Furukawa, H., et al. (1983) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)81601-9 · Cited by 16
Simultaneous ethambutol & isoniazid resistance in clinical isolates of Mycobacterium tuberculosis.
Gupta, P., Jadaun, G. P. S., Das, R., et al. (2006) · PubMed · Cited by 16
In Vitro Susceptibility of Mycobacterium tuberculosis Clinical Isolates to Garenoxacin and DA-7867
Cabrera, L. V., Castro‐Garza, J., Rendón, A., Ocampo‐Candiani, J., Welsh, O., Choi, S. H., Blackwood, K. S., & Molina-Torres, C. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4351-4353.2005 · Cited by 14
Anucleate Cell Blue Assay: a Useful Tool for Identifying Novel Type II Topoisomerase Inhibitors
Oyamada, Y., Ito, H., Fujimoto-Nakamura, M., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.348-350.2006 · Cited by 13
Two thiolactones from Streptomyces TUE 2476.
Jizba, J. V., Sedmera, P., Vaněk, Z., et al. (1985) · The Journal of Antibiotics · doi:10.7164/antibiotics.38.111 · Cited by 11
Potkar, C. N., Gogtay, N., Gokhale, P. C., Kshirsagar, N. A., Ajay, S., Cooverji, N. D., & Bruzzese, T. (1999) · Chemotherapy · doi:10.1159/000007176 · Cited by 10
Gallen, C. S. (2015) · Antibiotics and chemotherapy/Antibiotica et chemotherapia · doi:10.1159/000386815 · Cited by 7
Cited by
Biological Activities of Hydrazone Derivatives
Rollas, S., & Küçükgüzel, S. G. (2007) · Molecules · doi:10.3390/12081910 · Cited by 1,220
Lilienkampf, A., Mao, J., Wan, B., Wang, Y., Franzblau, S. G., & Kozikowski, A. P. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900003c · Cited by 308
Raman, K., Yeturu, K., & Chandra, N. (2008) · BMC Systems Biology · doi:10.1186/1752-0509-2-109 · Cited by 280
Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis
Sacchettini, J. C., Rubin, E. J., & Freundlich, J. S. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1816 · Cited by 256
Sequential assembly of the septal cell envelope prior to V snapping in Corynebacterium glutamicum
Zhou, X., Rodriguez-Rivera, F. P., Lim, H. C., Bell, J. C., Bernhardt, T. G., Bertozzi, C. R., & Theriot, J. A. (2019) · Nature Chemical Biology · doi:10.1038/s41589-018-0206-1 · Cited by 61
Metadata
- Authors
- Janin, Y. L.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 15
- Issue
- 7
- Pages
- 2479-2513
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W1968397983
- Cited by
- 485
- References
- 377
- FWCI
- 26.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.